Sage Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch SAGE and buy or sell other stocks, ETFs, and their options commission-free!

About SAGE

SAGE Therapeutics, Inc. is a biopharmaceutical company, which engages in providing solutions to brain health medicines. It focuses on diseases and disorders of the brain. 

CEO
Barry E. Greene
CEOBarry E. Greene
Employees
353
Employees353
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2010
Founded2010
Employees
353
Employees353

SAGE Key Statistics

Market cap
561.72M
Market cap561.72M
Price-Earnings ratio
-1.77
Price-Earnings ratio-1.77
Dividend yield
—
Dividend yield—
Average volume
5.53M
Average volume5.53M
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$10.74
52 Week high$10.74
52 Week low
$4.62
52 Week low$4.62

People also own

Based on the portfolios of people who own SAGE. This list is generated using Robinhood data, and it’s not a recommendation.
NIO
Moderna
Alibaba
Pfizer
Plug Power
Snap
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.